AAAAI: Long-Acting Beta Agonist Combo Okay for Kids – MedPage Today


Internal Medicine News Digital Network

AAAAI: Long-Acting Beta Agonist Combo Okay for Kids
MedPage Today
Explain that a single-center retrospective study found no increase in pediatric intensive care unit admissions for asthma patients on the combination of long-acting beta agonists and inhaled corticosteroids. Note that the study compared outcomes for
No Benefit to Increased Inhaled Steroids in Asthma ExacerbationInternal Medicine News Digital Network

all 2 news articles »

View full post on asthma – Google News

AAAAI: Asthma Tracks Childhood Obesity – MedPage Today


TheMedGuru

AAAAI: Asthma Tracks Childhood Obesity
MedPage Today
Explain that overweight children who become overweight as young adults appeared to have an increased risk of developing asthma compared with children who didn't carry around extra pounds. Note that that children who are overweight as 6-8 years olds and
People with asthma at greater risk of diabetes, heart disease–studyTheMedGuru

all 2 news articles »

View full post on asthma – Google News

Could Differences In Lung Defects Be Linked To Gender? – Medical News Today (press release)

Could Differences In Lung Defects Be Linked To Gender?
Medical News Today (press release)
Researchers from the University of Wisconsin have raised questions about whether differences in lung defects could be linked to gender in a study presented at the 2011 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI).
Asthma Associated with Increased Risk of Diabetes, Heart DiseaseHealthCanal.com
Severe Eczema Linked to Lasting Milk, Egg Allergy in KidsU.S. News & World Report
Revalesio To Present Research On The Anti-Inflammatory Effects Of RNS60 In AsthmaBiomed Middle East
KBOI –Shreveport Times –TopNews United States
all 23 news articles »

View full post on asthma – Google News

Asthma Worse In Children, Novartis’ Xolair Recommended – Medical News Today


LiveScience.com

Asthma Worse In Children, Novartis' Xolair Recommended
Medical News Today
A new study suggests that Novartis drug Xolair may aid in the treatment of asthma, the leading cause of chronic illness in children, especially for those living in highly polluted inner-city areas. Asthma affects as many as 10% to 12% of children in
Omalizumab 'cuts seasonal asthma attacks in youth'Sify
Omalizumab improves asthma control in inner-city childrenClinical Advisor
Drug may relieve kids' asthma in the fallmsnbc.com
MedPage Today –WebMD –U.S. News & World Report
all 50 news articles »

View full post on asthma – Google News

Asthma Drug Cuts Seasonal Flares for Inner-City Kids – MedPage Today

Asthma Drug Cuts Seasonal Flares for Inner-City Kids
MedPage Today
Explain that a monoclonal antibody directed against IgE (omalizumab) improved asthma symptoms and reduced the need for other controller medications among inner-city children with persistent allergic asthma
Xolair Relieves Kids' Seasonal Asthma Attacks: StudyWebMD
Omalizumab Improves Asthma Control in Inner-City ChildrenMedscape
Xolair Reduces Seasonal Asthma Attacks for Inner City Kids: StudyU.S. News & World Report
Bloomberg –7Online.com –Internal Medicine News Digital Network
all 24 news articles »

View full post on asthma – Google News